Belgium· BE-AMP-SAM473226-00

Saxenda 6 mg/ml

A liraglutide product containing liraglutide, registered in Belgium by Novo Nordisk. The same ATC class is registered in 16 of our 19 countries.

ATC A10BJ02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about liraglutideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Liraglutide is registered in 16 of 19 countries.

Countries holding a registration under ATC A10BJ02 (liraglutide), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
10 of them publish a price we can compare per daily dose

Search liraglutide products by name

Liraglutide · ATC A10BJ02

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Liraglutide
Manufacturer: Novo Nordisk
Country: Belgium (BE)
ATC code: A10BJ02
ATC class: Liraglutide
Defined daily dose: 1.5 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 4

be_apb
3384401
be_apb
4250403
be_apb
4913570
be_apb
4938247

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

309 interactions on record for liraglutide.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check liraglutide against other medicines How interaction checks work

Liraglutide · interactions on record

309 records

3 severe
260 moderate
46 minor

Most severe, free to view

GatifloxacinJ01MA16severe
SucralfateA02BX02moderate
ThiethylperazinA04AB03moderate
TriflupromazinA04AD06moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Liraglutide in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liraglutide products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

Austria · Ejulir, Lirabelin
Bulgaria · Зеглуксен
Czechia · Ejulir, Plyzari
Germany · Byesilor, Diavic
Denmark · Ejulir, Liraglutid "biogaran"
Estonia · Liraglutide Zentiva, Siluxir
Spain · Byesilor, Diavic
Finland · Diavic, Metlyra
France · Liendax, Liraglutide Biogaran
United Kingdom (Northern Ireland) · Diavic, Ligobesy
Croatia · Zegluxen
Hungary · Liendax
Ireland · Ejulir
Iceland · Ablymico, Liraglutide Stada
Italy · Byesilor, Diavic
Liechtenstein · Ablymico, Liraglutide Stada
Lithuania · Liraglutide Zentiva
Luxembourg · Zinnentis
Latvia · Liraglutide Zentiva, Siluxir
Netherlands · Byesilor, Diavic
Norway · Ablymico, Liraglutid Zentiva
Poland · Byesilor, Diavic
Portugal · Liraglutido Farmoz, Liraglutido Pentafarma
Romania · Byesilor, Diavic
Sweden · Diavic, Ejulir
Slovakia · Sudaclin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/cd8bef75-eae2-4891-8614-0c0ce1bd51b7
GET /v1/drugs/cd8bef75-eae2-4891-8614-0c0ce1bd51b7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection in pre-filled pen",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Saxenda 6 mg/ml",
  "name_fr": "Saxenda 6 mg/ml",
  "name_nl": "Saxenda 6 mg/ml",
  "amp_code": "SAM473226-00",
  "strengths": [
    "6.0000"
  ],
  "pack_count": 6,
  "substances": [
    "Liraglutide",
    "Disodium Hydrogen Phosphate Dihydrate",
    "Propylene Glycol",
    "Sodium Hydroxide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Liraglutide",
  "authorisation_numbers": [
    "EU/1/15/992/001",
    "EU/1/15/992/002",
    "EU/1/15/992/003"
  ]
}

API reference MCP server Plans

See everything about liraglutide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console